Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FLC”

9 trials

Showing 9 of 9 results

Testing effectiveness (Phase 2)Looking for participantsNCT06027086
What this trial is testing

DRP-104 (Glutamine Antagonist) in Combination With Durvalumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)

Who this might be right for
Fibrolamellar Hepatocellular Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 27
Not applicableStudy completedNCT01572857
What this trial is testing

Urinary Protein/Creatinine Ratio in a Single Urine Sample Versus 24-hour Proteinuria in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Rennes University Hospital 30
Testing effectiveness (Phase 2)WithdrawnNCT04025567
What this trial is testing

Vancomycin in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLC) Oral

Who this might be right for
Metastatic Hepatocellular CarcinomaHepatocellular Carcinoma
National Cancer Institute (NCI)
Early research (Phase 1)Not Yet RecruitingNCT07430202
What this trial is testing

A DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104, Nivolumab, and Ipilimumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)

Who this might be right for
Liver Cancer (Fibrolamellar Hepatocellular Cancer (FLC))
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 27
Not applicableWithdrawnNCT02201758
What this trial is testing

Flaxseed Lignan-Enriched Complex (FLC) for the Treatment of Patients With Ulcerative Colitis (UC): A Pilot Assessment

Who this might be right for
Ulcerative Colitis
University of Saskatchewan
Early research (Phase 1)Looking for participantsNCT06789198
What this trial is testing

Peptide Vaccine for Fibrolamellar Hepatocellular Carcinoma Patients and Other Tumor Entities Carrying the Driver Fusion DNAJB1-PRKACA

Who this might be right for
Fibrolamellar Hepatocellular Carcinoma (FLC)
University Hospital Tuebingen 20
Not applicableStudy completedNCT04874519
What this trial is testing

Registry to Collect Health Information Related to Fibrolamellar Cancer

Who this might be right for
Fibrolamellar CancerFLCLiver Cancer
Memorial Sloan Kettering Cancer Center 12
Early research (Phase 1)Looking for participantsNCT04248569
What this trial is testing

DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma

Who this might be right for
Fibrolamellar Hepatocellular Carcinoma (FLC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 56
Testing effectiveness (Phase 2)Study completedNCT02234986
What this trial is testing

A Multi-center, Open-label Study of Oral ENMD-2076 for the Treatment of Patients With Advanced Fibrolamellar Carcinoma

Who this might be right for
Advanced Adult Hepatocellular CarcinomaAdvanced Fibrolamellar Carcinoma
CASI Pharmaceuticals, Inc. 35

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation